Jon Kessler compensation by year
HEALTHEQUITY Summary Compensation Table · all 10 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Salary | $400,000 | $400,000 | $400,000 | $483,334 | $500,000 | $666,667 | $700,000 | $700,000 | $700,000 | $742,572 |
| Bonus | $300,000 | $272,371 | $383,765 | $610,854 | $750,000 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $2,333,333 | $2,466,667 | $2,666,667 | $8,012,443 | $8,711,947 | $11,849,492 | $11,926,568 | $10,885,969 |
| Option awards | $0 | $0 | $1,166,667 | $1,233,333 | $1,333,333 | $0 | $0 | $0 | $0 | $0 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 | $646,700 | $525,000 | $840,000 | $805,000 | $964,344 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $9,750 | $8,870 | $10,848 | $14,482 | $15,794 | $73,673 | $10,675 | $10,675 | $16,450 | $17,482 |
| Total | $709,750 | $681,241 | $4,294,613 | $4,808,670 | $5,265,794 | $9,399,483 | $9,947,622 | $13,400,167 | $13,448,018 | $12,610,368 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: HEALTHEQUITY, INC. DEF 14A filed May 13, 2025, accession 0001428336-25-000016, and prior-year filings. Open the filing on EDGAR.
How this page was built: the HEALTHEQUITY, INC. filed document, accession 0001428336-25-000016. Every figure is read from that document and cited to the page and table it appears in. Filed May 13, 2025.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 270,966 | $29,920,066 | — |
| RSU | 205,055 | $22,642,173 | — |
| RSU | 188,786 | $20,845,750 | — |
| Option | 47,859 | — | $61.72 |
| Option | 52,229 | — | $41.28 |
| Option | 51,125 | — | $73.61 |
Per the Outstanding Equity Awards at Fiscal Year-End table in HEALTHEQUITY, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
21 Form 4 lines since the FY2025 proxy (filed May 13, 2025)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2025-06-06 | Exercise or conversion | — | 38,343 | $73.61 | 387,693 |
| 2025-06-06 | Sale | — | 62,827 | $111.84 | 324,866 |
| 2025-06-06 | Sale | — | 15,427 | $112.70 | 253,510 |
| 2025-06-06 | Exercise or conversion | — | 23,930 | $61.72 | 159,985 |
| 2025-06-06 | Exercise or conversion | — | 12,782 | $73.61 | 172,767 |
| 2025-06-06 | Sale | — | 19,082 | $112.39 | 101,235 |
| 2025-06-06 | Sale | — | 16,547 | $111.98 | 84,688 |
| 2025-06-06 | Exercise or conversion | — | 23,929 | $61.72 | 349,350 |
The 8 most recent of 21 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments HEALTHEQUITY discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $750,000 | $0 | $30,981 | $1,745,325 |
| Death | $0 | $0 | $0 | $964,344 |
| Change in control and involuntary termination | $1,125,000 | $38,365,429 | $46,472 | $40,501,245 |
| Change in control and resignation for good reason | $1,125,000 | $38,365,429 | $46,472 | $40,501,245 |
| Resignation for good reason, no change in control | $750,000 | $0 | $30,981 | $1,745,325 |
| Disability | $0 | $0 | $0 | $964,344 |
Per the Potential Payments Upon Termination or Change in Control table in HEALTHEQUITY, INC.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
HEALTHEQUITY’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jon Kessler · this page | Former President and Chief Executive Officer | $12,610,368 |
| Scott Cutler | President and Chief Executive Officer | $8,277,080 |
| Michael Fiore | Executive Vice President and Chief Commercial Officer | $7,401,319 |
| James Lucania | Executive Vice President and Chief Financial Officer | $5,581,044 |
| Elimelech Rosner | Executive Vice President and Chief Technology Officer | $4,945,389 |
| Selim Aissi | Former Executive Vice President and Chief Security Officer | $3,702,465 |
| Delano Ladd | Executive Vice President and General Counsel | $3,354,233 |
| Stephen Neeleman | Founder and Vice Chairman | $2,888,827 |
Board service
HEALTHEQUITY board · FY2023How this board is paid
Company policy: HEALTHEQUITY pays directors a $60,000 cash retainer and $240,000 in equity. As stated in HEALTHEQUITY's FY2026 proxy.
The full HEALTHEQUITY compensation record
free company briefThis page is one person within HEALTHEQUITY's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the HEALTHEQUITY proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are HEALTHEQUITY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.